A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.

MLA

Crist, R. C., et al. “A Polymorphism in the OPRM1 3’-Untranslated Region Is Associated with Methadone Efficacy in Treating Opioid Dependence.” The Pharmacogenomics Journal, vol. 18, no. 1, Jan. 2018, pp. 173–79. EBSCOhost, https://doi.org/10.1038/tpj.2016.89.

APA

Crist, R. C., Doyle, G. A., Nelson, E. C., Degenhardt, L., Martin, N. G., Montgomery, G. W., Saxon, A. J., Ling, W., & Berrettini, W. H. (2018). A polymorphism in the OPRM1 3’-untranslated region is associated with methadone efficacy in treating opioid dependence. The Pharmacogenomics Journal, 18(1), 173–179. https://doi.org/10.1038/tpj.2016.89

Chicago

Crist, R C, G A Doyle, E C Nelson, L Degenhardt, N G Martin, G W Montgomery, A J Saxon, W Ling, and W H Berrettini. 2018. “A Polymorphism in the OPRM1 3’-Untranslated Region Is Associated with Methadone Efficacy in Treating Opioid Dependence.” The Pharmacogenomics Journal 18 (1): 173–79. doi:10.1038/tpj.2016.89.